Total
USD $0.00
 
China

Company Overview of China National Medicines Corporation Ltd (国药集团药业股份有限公司)

An EMIS Company Report EMIS is an ISI Emerging Markets Group Company Company Description

The company belongs to the pharmaceutical industry's investment management enterprise, the pharmaceutical industry specific business areas, mainly in its holding, shares of the company started. The company mainly engaged in pharmaceutical distribution business, including, manufacture and sale of medical equipment, pharmaceutical manufacturing business three categories. Holding shares in the company of the companies that have a direct relationship between the pharmaceutical distribution business. Company owned 10 subsidiaries, mainly in the pharmaceutical distribution business Sinopharm, Medicines and Chinese pharmaceutical company. Among them, two Sinopharm and Medicines Company's business includes pharmaceutical net sales, drug allocation, three retail drugs. In addition, the company in the field of narcotics distribution monopoly is its most prominent feature. In addition to narcotic drugs and other specialty pharmaceuticals, the company's distribution and agents to import, joint venture based drugs. Domestic production base in the three anesthetics, the company has two shares: 47.1% stake in Qinghai Pharmaceutical Group and Yichang Humanwell Pharmaceutical 20 percent.

Need a report on this company? USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Chinese Format: PDF Download Most recent financial data: 2017 Buy full report

Report contents

On purchasing the report for this company you will have access to a PDF containing the most recent data for China National Medicines Corporation Ltd from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Contact Information

Headquarters
Ja 12 Yongwai Sunyenxing Lane Jongwun Dt. Beijing
Beijing; Beijing; Postal Code: 100077

Tel: 86-10-6727
Fax: 86-10-6727

Email:
@sinopharm.com;Wangke20@sinopharm.com;gygfzqb@sinopharm.com

Website:
http://www.cncm.com.cn

Basic Information
Total Employees:
2,770 (2017)
Outstanding Shares:
Provided in the purchased report
Registered Capital:
Provided in the purchased report
Financial Auditors:
Provided in the purchased report
Incorporation Date:
December 21, 1999
Key Executives
Provided in the purchased report
Chairman
Provided in the purchased report
Chairman of the Supervisory Board
Provided in the purchased report
Director
Provided in the purchased report
Director
Provided in the purchased report
Director
More
Ownership Details
Sinopharm Group Co., Ltd.
44.01%
China Life Insurance Company Limited Traditional
2.39%
Da Cheng Value Growth Fund
2.08%
National Social Security Fund 418 Portfolio
1.49%
China Universal Medicine Health Care Equity Securi
1.39%
More
Subsidiaries
Guo Yao Kong Gang Bei Jing Guo Ji Mao Yi You Xian Gong Si
100%
China National Guorui Medicines Corporation Ltd.
98.31%
Guoyiao Logistics Ltd.
56.3%
More
M&A deals (Not included in report)

Report contents

On purchasing the report for this company you will have access to a PDF containing the most recent data for China National Medicines Corporation Ltd from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
Key Financial Highlights
Annual growth percentages* for latest two years in USD terms. Absolute financial data is included in the purchased report.
Net sales revenue
10.86%
Total operating revenue
10.89%
Operating profit (EBIT)
14.42%
EBITDA
19.85%
Net Profit (Loss) for the Period
15.17%
Total assets
4%
Total equity
6.82%
Operating Profit Margin (ROS)
0.15%
Net Profit Margin
0.14%
Return on Equity (ROE)
-0.03%
Debt to Equity Ratio
-8.42%
Quick Ratio
1.2%
Cash Ratio
13.13%
* Growth figures are affected by the currency rate changes.
Company News (Not included in report)
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Request a demonstration of the EMIS service

To view more information, Request a demonstration of the EMIS service